title: Oncodiagnosis panel: 2002. Primary glial neoplasm or less likely an intracranial abscess.
authors.affiliation: Department of Oncology, Mayo Clinic, 200 SW 1st St, Rochester, MN 55905, USA.
authors.forename: Paul D
authors.initials: PD
authors.lastname: Brown
authors.forename: John T
authors.initials: JT
authors.lastname: Wald
authors.forename: Mike W
authors.initials: MW
authors.lastname: McDermott
authors.forename: Glen S
authors.initials: GS
authors.lastname: Baumann
authors.forename: Tim F
authors.initials: TF
authors.lastname: Cloughesy
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001922:Brain Abscess / Q000175:diagnosis*; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003399:Craniotomy; D003560:Cysts / Q000175:diagnosis* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005625:Frontal Lobe / Q000473:pathology / Q000601:surgery; D000077156:Gefitinib; D005909:Glioblastoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010296:Parietal Lobe / Q000473:pathology / Q000601:surgery; D011799:Quinazolines / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant; D020266:Radiotherapy, Conformal
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib